PMID- 18317592 OWN - NLM STAT- MEDLINE DCOM- 20080516 LR - 20211020 IS - 0021-9738 (Print) IS - 0021-9738 (Linking) VI - 118 IP - 4 DP - 2008 Apr TI - Estrogen receptor beta protects against acoustic trauma in mice. PG - 1563-70 LID - 10.1172/JCI32796 [doi] AB - The hormone estradiol affects the auditory system both by itself and by its interaction with neuroprotective factors. In this study, we examined the role of estrogen receptors (ERs) in response to auditory trauma. We found a ligand-dependent protective role for ERbeta in the auditory system by investigating mice deficient in ERalpha (ERKO mice), ERbeta (BERKO mice), and aromatase (ARKO mice). Basal auditory brainstem response (ABR) thresholds were similar in all animals. An acoustic trauma causing a temporary hearing loss raised ABR thresholds in male and female BERKO and ARKO mice compared with WT and ERKO mice. The ERalpha-selective agonist, propyl(1H) pyrazole-1,3,5-triyl-trisphenol (PPT), partially protected ARKO mice from trauma, while the ERbeta-selective agonist, 2,3-bis (4-hydroxyphenyl)-propionitrile (DPN), protected WT and ARKO mice. Immunohistochemistry and western blotting confirmed the expression of ERbeta in cochlea of WT males and females. Levels of brain-derived neurotrophic factor (BDNF), a neuroprotective peptide that can be induced by estrogen, was lower in BERKO and ARKO mice compared with WT. DPN treatment increased BDNF expression in ARKO mice. These data indicate ERbeta-mediated neuroprotection involving BDNF in the auditory system of males and females. FAU - Meltser, Inna AU - Meltser I AD - Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. FAU - Tahera, Yeasmin AU - Tahera Y FAU - Simpson, Evan AU - Simpson E FAU - Hultcrantz, Malou AU - Hultcrantz M FAU - Charitidi, Konstantina AU - Charitidi K FAU - Gustafsson, Jan-Ake AU - Gustafsson JA FAU - Canlon, Barbara AU - Canlon B LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Clin Invest JT - The Journal of clinical investigation JID - 7802877 RN - 0 (2,3-bis(4-hydroxyphenyl)-propionitrile) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Estrogen Receptor alpha) RN - 0 (Estrogen Receptor beta) RN - 0 (Nitriles) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/metabolism MH - Cochlea/metabolism MH - Estrogen Receptor alpha/agonists/deficiency/genetics/metabolism MH - Estrogen Receptor beta/agonists/deficiency/genetics/*metabolism MH - Female MH - Hearing Loss, Noise-Induced/drug therapy/genetics/*metabolism/pathology MH - Immunohistochemistry MH - Male MH - Mice MH - Mice, Knockout MH - Nitriles/therapeutic use PMC - PMC2260908 EDAT- 2008/03/05 09:00 MHDA- 2008/05/17 09:00 PMCR- 2008/04/01 CRDT- 2008/03/05 09:00 PHST- 2007/05/24 00:00 [received] PHST- 2008/01/09 00:00 [accepted] PHST- 2008/03/05 09:00 [pubmed] PHST- 2008/05/17 09:00 [medline] PHST- 2008/03/05 09:00 [entrez] PHST- 2008/04/01 00:00 [pmc-release] AID - 32796 [pii] AID - 10.1172/JCI32796 [doi] PST - ppublish SO - J Clin Invest. 2008 Apr;118(4):1563-70. doi: 10.1172/JCI32796.